DYRK2 and triple-negative breast carcinoma: For example, recent studies have found that DYRK2 is a major regulator of the hitherto unknown heat shock factor 1(HSF1) pathway, promoting triple-negative breast cancer(TNBC) cell survival18.However there is still a need to demonstrate the relationship between DYRK2 and various tumours through clinical big data analysis.